Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna-Victoria De Keersmaecker

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
European Journal of Neurology|November 11, 2025
Recent Advances in Interventions Targeting Remyelination and a Systematic Review of Remyelinating Effects of Approved Disease-Modifying Treatments for Multiple SclerosisAnna-Victoria De Keersmaecker, Eline van Doninck, Inez Wens, et al.
Acta Neurologica Belgica|November 3, 2025
Cognitive functioning in multiple sclerosis with focus on brainstem volumeEline Van Doninck, Anna-Victoria De Keersmaecker, Marie D'hooghe, et al.
Frontiers in Immunology|April 29, 2024
A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trialAnna-Victoria De Keersmaecker, Eline Van Doninck, Veronica Popescu, et al.
Eclinicalmedicine|March 20, 2026
Stride-level measurement of gait as an early sensitive marker of disability progression in ambulatory patients with multiple sclerosisMargaux Poleur, Barbara Willekens, Bertrand Degos, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
European Journal of Neurology|November 11, 2025
Recent Advances in Interventions Targeting Remyelination and a Systematic Review of Remyelinating Effects of Approved Disease-Modifying Treatments for Multiple SclerosisAnna-Victoria De Keersmaecker, Eline van Doninck, Inez Wens, et al.
Acta Neurologica Belgica|November 3, 2025
Cognitive functioning in multiple sclerosis with focus on brainstem volumeEline Van Doninck, Anna-Victoria De Keersmaecker, Marie D'hooghe, et al.
Frontiers in Immunology|April 29, 2024
A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trialAnna-Victoria De Keersmaecker, Eline Van Doninck, Veronica Popescu, et al.
Eclinicalmedicine|March 20, 2026
Stride-level measurement of gait as an early sensitive marker of disability progression in ambulatory patients with multiple sclerosisMargaux Poleur, Barbara Willekens, Bertrand Degos, et al.
Pageof 1